Cancer Drugs News

Cancer Treatment Hospitals Delhi , India

Top Cancer Treatment Hospitals in Delhi (India) About MedsDelta.com: We are Leading Supplier And Exporter of all Lifesaving pharmaceutical Such As Cancer, Hepatitis, Acne, Arthritis, HIV AIDS, Etc, Call us For any Cancer drugs +919971646666 or QQ:3451266709 ” A huge number of individuals are determined to have Cancer consistently in India and over the globe yet after a conclusion of growth genuine adventure starts as there are more than 200 sorts of tumor on the Read more...

Cancer Drugs News

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

Zydelig (Idelalisib) Chemotherapy Drug Information Individuals with specific sorts of leukemia and lymphoma that has returned after treatment now have another medication treatment to attempt. The U.S. Sustenance and Drug Administration (FDA) has endorsed idelalisib (Zydelig) for individuals with backslid perpetual lymphocytic leukemia (CLL), backslid follicular B-cell non-Hodgkin lymphoma, and backslid little lymphocytic lymphoma (another sort of non-Hodgkin lymphoma). Zydelig is a pill taken twice per day. It focuses on a protein found in the Read more...

Cancer Drugs News

Takeda Pharma announces FDA Accelerated Approval of ALUNBRIG™ (brigatinib) for Lung Cancer

Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology Takeda Pharmaceutical Company Limited declared that ALUNBRIG™ (brigatinib) has gotten Accelerated Approval from the U.S. Sustenance and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-little cell lung disease (NSCLC) who have advanced on or are narrow minded to crizotinib. This sign is endorsed under Accelerated Approval in view of tumor Read more...

Indian Generic Drugs

Scapho Injection : Secukinumab Novartis launches new drug for psoriasis treatment in India

There is a good news for patients in India suffering from psoriasis particularly plaque psoriasis. Novartis has announced launch of a new drug secukinumab in India with brand name Scapho Injection for the treatment of moderate-to-severe plaque psoriasis in Patients who are candidates for systemic therapy or phototherapy. Secukinumab Injection which is already approved in over 50 countries for the treatment of plaque psoriasis has been approved by the Drug Controller General of India (DCGI). Read more...

Cancer Medicine

Lynparza Novartis olaparib Capsule , First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Astra Zeneca’s Lynparza olaparib slowed the progression of breast blight acquired in allotment by mutations in the BRCA gene, an affiliated action that causes up to 3% of all breast cancers. These cancers are decidedly harder to treat, and some women who analysis absolute for BRCA genes opt for bifold mastectomies in adjustment to lower their risk. In a abstraction of 302 women whose breast blight had spread, olaparib Lynparza Capsules bargain the accident of blight growing Read more...

Cancer Medicine

Opdivo, Keytruda launches in India slated by End of Year

indian cancer sufferers may be set to acquire two of the sector’s main oncology tablets, msd’s keytruda and bristol-myers squibb’s opdivo, through the give up of this 12 months in step with the financial times. keytruda, which has constantly completed well in lung cancer and advanced cancer,changed into recently authorised the drug controller popular of india, in line with a top fitness ministry legitimate. opdivo, alternatively, recently acquired horrific news as it did not meet Read more...

Cancer Medicine

Roche’s Alecensa Alectinib bests Pfizer’s Xalkori crizotinib lung cancer trial

Alecensa Alectinib Capsules Who is alectinib for? Alectinib is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant of crizotinib, a drug for ALK-positive NSCLC widely approved (e.g. in USA by FDA  and in Europe by EMA ) Roche has bestowed late-stage information showing that its Alecensa was superior to on progression-free survival in patients with a particular style of carcinoma. Read more...

Cancer Medicine

Dr Reddy’s Labs receives US FDA marketing approval for generic Doxil ( doxorubicin liposomal)

 Dr Reddy’s Labs receives US FDA marketing approval for generic Doxil Dr Reddy’s Laboratories Ltd. has received approval from the US Food and Drug Administration (FDA) to launch doxorubicin hydrochloride liposome injection, a therapeutic equivalent generic version of Doxil (doxorubicin hydrochloride liposome injection), for intravenous use, in the United States market. The  US FDA approval is an outcome of extensive collaboration with the company’s partner, Natco Pharma Ltd., on R&D and manufacturing capabilities. “This approval Read more...

Indian Generic Drugs

Bedaquiline : The roll out of a TuberCulosis curing miracle drug India

Treating drug resistant TB can take years and can cost 200 times as much as treating ordinary diseases. Approval for the drug Bedaquiline marks the first time in 40 years that FDA has approved the drug that attacks TB in different ways from current treatment. Discovered by scientists at Janssen, the pharmaceuticals unit of Johnson & Johnson, Monday saw the roll out of this ‘miracle drug’. Sunil Khaparde, Deputy Director General, Central TB division, Union Read more...

Cancer Medicine

Natco Launches Pomalid Capsules Generic Pomalidomide Capsules in India

Blood Cancer Medicine  Pomalidomide Capsule By Natco Pharma India Hyderabad-based drug maker Natco Pharma Ltd on Wednesday announced that it has launched a generic version of pomalidomide 1 mg, 2 mg, and 4 mg capsules in India. Pomalidomide is anti-angiogenic and also acts as an immunomodulator. The drug is sold by American biotechnology company   Celgene Inc.,in the USA, under the brand name Pomalyst. “Pomalidomide is a thalidomide analogue indicated, in combination with dexamethasone, for Read more...

Hepatitis Medicine India

BioGeneric Epclusa (sofosbuvir/velpatasvir) hepatitis C drug Velpanat in India by Natco Pharma

Velpatasvir Sofosbuvir Tablets Natco Pharma India NatcoPharma Limited has launched a hepatitis C drug – a fixed dose combination of sofosbuvir (400 mg) & velpatasvir (100 mg) – under the brand name of Velpanat in India. Velpanat is the generic version of Epclusa, manufactured by Gilead Sciences Inc globally Epclusa is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection. Epclusa is a Read more...